Study links schizophrenia to increased risk of sudden cardiac death

The lifetime risk of an unexpected and sudden death from a cardiovascular cause in the absence of pre-existing heart disease-;known as sudden cardiac death-;is more than 4 times higher for people with schizophrenia than it is for the general population, indicates Danish research published online in the journal Heart.

BioCryst Pharmaceuticals Inc Patent Filing for Complement System Inhibitors

Share this article According to GlobalData’s company profile on BioCryst Pharmaceuticals, Cancer treatment biomarkers was a key innovation area identified from patents. BioCryst Pharmaceuticals‘s grant

April 24, 2024

Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement – Psychedelic Alpha

TORONTO, July 13, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) (“Reunion” or the “Company”), a clinical-stage biopharmaceutical company committed to developing

July 13, 2023

Responders to PCI for Angina Relief Identified by Chest Pain Type

PARIS — Whether a person had chest pains resolved by angioplasty hinged on the nature, not the severity, of their presenting symptoms, an ORBITA-2 analysis

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.